Macnaughtan, Jane
Mookerjee, Rajeshwar P.
van der Merwe, Schalk
Jalan, Rajiv
Article History
Received: 19 September 2016
Accepted: 2 December 2016
First Online: 4 January 2017
Change Date: 31 May 2018
Change Type: Update
Change Details: A correction has been published and is appended to both the HTML and PDF versions of this paper. The error has been fixed in the paper.
Change Date: 28 April 2017
Change Type: Update
Change Details: A correction has been published and is appended to both the HTML and PDF versions of this paper. The error has been fixed in the paper.
Change Date: 31 May 2018
Change Type: Erratum
Change Details: Scientific Reports 7: Article number: 40157; published online: 04 January 2017; updated: 31 May 2018 In the Corrigendum published 28 April 2017, the author Schalk van der Merwe was incorrectly indexed. This error has now been corrected.
Competing interests
: Rajiv Jalan has served on the Scientific Advisory Board for Conatus Pharma. He has received lecture fees from Gambro and has an on-going research collaboration with Gambro, Grifols and is the Principal Investigator of an Industry sponsored study (Sequana Medical). He is also inventor for the drug, L-ornithine phenyl acetate (OCR-002) which UCL has licensed to Ocera Therapeutics. He is also the founder of UCL spin-out company Yaqrit ltd. and Cyberliver ltd.